Hi there,
The first link is an old article discussing 3 agents targeting leukemia stem cells. Then, I found the second link talking about commercialing one of the agents.
Does anyone know more about this subject?
Thanks!
http://www.ncbi.nlm....les/PMC1988840/
http://www.marketwir...bya-2010865.htm
Aim at leukemia stem cells
Started by
missjoy
, Feb 10 2016 09:38 AM
3 replies to this topic
#2
r06ue1
-
- Members
-
- 426 posts
Advanced Member
- LocationEarth, Solar System, Milky Way, Local Group, Virgo Supercluster, Laniakea
Posted 10 February 2016 - 11:50 AM
Woah, that sounds just like DRACO Anti-Viral (a broad spectrum anti-viral that kills all virus infected cells) that I have been following for years. Hope it does what it says it can do.
08/2015 Initial PCR: 66.392%
12/2015 PCR: 1.573%
03/2016 PCR: 0.153%
06/2016 PCR: 0.070%
09/2016 PCR: 0.052%
12/2016 PCR: 0.036%
03/2017 PCR: 0.029%
06/2017 PCR: 0.028%
09/2017 PCR: 0.025%
12/2017 PCR: 0.018%
Taking Imatinib 400 mg
#3
r06ue1
-
- Members
-
- 426 posts
Advanced Member
- LocationEarth, Solar System, Milky Way, Local Group, Virgo Supercluster, Laniakea
Posted 10 February 2016 - 01:27 PM
Difficult to get any information on that drug or that company, looking up their stock symbol doesn't tell me much either. Not sure how reliable their information is.
08/2015 Initial PCR: 66.392%
12/2015 PCR: 1.573%
03/2016 PCR: 0.153%
06/2016 PCR: 0.070%
09/2016 PCR: 0.052%
12/2016 PCR: 0.036%
03/2017 PCR: 0.029%
06/2017 PCR: 0.028%
09/2017 PCR: 0.025%
12/2017 PCR: 0.018%
Taking Imatinib 400 mg
#4
Trey
-
- PS Beta Group
-
- 1,705 posts
Advanced Member
- LocationSan Antonio, Texas
Posted 10 February 2016 - 10:24 PM
These inhibit NF-κB, which plays a key role in immune response. This is more often found in lymphoid cells than myeloid cells, so I am not sure why it would be useful in myeloid leukemias. But we can only wait and see what testing shows, if they are ever properly tested.
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users
